Here, they categorized cases with loss of DAXX and ATRX expression into well-differentiated NEC (NET G3), whereas cases with loss of Rb and abnormal p53 expression were categorized into poorly differentiated NEC, improving the accuracy of diagnosis especially for unclassifiable cases by morphologic diagnosis. Here, DAXX is linked to neuroendocrine carcinoma.